CD34 and acute myeloid leukemia: BCL-2 was found to be expressed in AML CD34+ progenitor cells and promyelocytes while this expression was absent in their heathy counterparts, and evidence was presented that induction chemotherapy resulted in selection for leukemic CD34+ cells expressing high levels of BCL-246.